Insider Trading January 23, 2026

Planet Labs Director Gadde Vijaya Disposes of $535K in Shares Amid Strategic Developments

Executive Stock Sale Occurs Concurrently with Company’s Multi-Year Contract and Stock Milestone Achievement

By Leila Farooq PL
Planet Labs Director Gadde Vijaya Disposes of $535K in Shares Amid Strategic Developments
PL

Gadde Vijaya, a director at Planet Labs PBC, executed the sale of 20,000 Class A Common Stock shares on January 22, 2026, totaling approximately $535,350. The sale comes as the company reached significant stock price milestones and secured a notable multi-year satellite services contract with the Swedish Armed Forces. These events have prompted upward revisions of price targets by multiple research firms.

Key Points

  • Director Gadde Vijaya sold 20,000 shares of Planet Labs stock valued at approximately $535,350 on January 22, 2026.
  • Planet Labs issued over 5 million Class A and about 580,000 Class B shares after meeting a stock price milestone set out in its 2021 merger agreement.
  • The company secured a multi-year satellite services contract with the Swedish Armed Forces, its third major contract in the last year impacting peace and security operations.

On January 22, 2026, Planet Labs PBC (NYSE: PL) director Gadde Vijaya sold 20,000 shares of Class A Common Stock, generating proceeds near $535,350. These shares exchanged hands over a series of transactions, with prices fluctuating between $26.76 and $26.815 per share. As a result of this disposition, Vijaya currently holds a direct ownership of 250,169 shares in the company.

In tandem with this insider transaction, Planet Labs recently reached a key stock milestone, triggering the release of additional shares. Specifically, the company issued 5,133,294 shares of Class A common stock and 584,052 shares of Class B common stock. This issuance follows the successful achievement of a stock price criterion detailed in the company’s 2021 merger agreement, which required the stock price to surpass $19.00 in at least 20 out of 30 consecutive trading days.

Complementing this milestone achievement, the company announced the signing of a multi-year contract with the Swedish Armed Forces. Valued in the low nine-figure range, this agreement represents Planet Labs’ third major satellite services contract within the past year. The contract scope includes the provision of satellites and associated data solutions designed to support peace and security operations.

Market analysts responded positively to these developments. Clear Street increased its price target for Planet Labs to $29.00, citing expectations of solid revenue growth and improved margins driven by the company’s strategic positioning. Morgan Stanley adjusted its target to $26.00 following the Swedish contract announcement, while Craig-Hallum raised its price target to $30.00, recognizing the importance of the company securing a third sovereign constellation deal within a relatively short timeframe.

Risks

  • Potential volatility in Planet Labs’ stock price could affect shareholder value and future insider trading activity.
  • Dependence on government contracts such as the Swedish Armed Forces agreement may carry risks related to contract renewal and geopolitical factors.
  • Achievement and maintenance of stock price milestones are necessary for future share releases and can be influenced by market conditions and company performance.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026